View Future GrowthMedix 과거 순이익 실적과거 기준 점검 1/6Medix은 연평균 6.2%의 비율로 수입이 증가해 온 반면, Media 산업은 수입이 7% 증가했습니다. 매출은 연평균 0.5%의 비율로 감소했습니다. Medix의 자기자본이익률은 12.2%이고 순이익률은 10.2%입니다.핵심 정보6.17%순이익 성장률5.29%주당순이익(EPS) 성장률Media 산업 성장률9.30%매출 성장률-0.48%자기자본이익률12.18%순이익률10.24%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.공시 • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026공시 • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025공시 • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025공시 • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025모든 업데이트 보기Recent updates공시 • Jun 16Medix Inc. (TSE:331A) announces an Equity Buyback for 400,000 shares, representing 5.22% for ¥188 million.Medix Inc. (TSE:331A) announces a share repurchase program. Under the program, the company will repurchase up to 400,000 shares, representing 5.22% of its issued share capital (excluding treasury stock), for a total purchase price of ¥188 million. The shares will be repurchased at a price of ¥470 per share. The purpose of the program is to enable flexible capital policies that respond to changes in the business environment. As of March 31, 2026, the company had 7,667,500 issued shares (excluding treasury stock) and 412,500 treasury shares.Reported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.공시 • May 14Medix Inc., Annual General Meeting, Jun 26, 2026Medix Inc., Annual General Meeting, Jun 26, 2026.Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.0%).분석 기사 • Feb 16Why Investors Shouldn't Be Surprised By Medix Inc.'s (TSE:331A) Low P/EWith a price-to-earnings (or "P/E") ratio of 7.6x Medix Inc. ( TSE:331A ) may be sending bullish signals at the moment...Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.공시 • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026공시 • Sep 16Medix Inc. (TSE:331A) announces an Equity Buyback for 600,000 shares, representing 7.47% for ¥308.4 million.Medix Inc. (TSE:331A) announces a share repurchase program. Under the program, the company will repurchase up to 600,000 shares, representing 7.47% of its issued share capital (excluding treasury stock), for a total purchase price of ¥308.4 million. The shares will be repurchased at a price of ¥514 per share. The purpose of the program is to enable flexible capital policies that respond to changes in the business environment. As of September 16, 2025, the company had 8,030,000 issued shares (excluding treasury stock) and 50,000 treasury shares.공시 • Sep 05Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million.Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million on September 4, 2025. A cash consideration of TWD 144 million will be paid by Medix Inc. Medix Inc. will pay an earnout payment of TWD 41 million cash. As part of consideration, TWD 185 million is paid towards common equity of Star To Asia Co., Ltd. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is September 30, 2025. The advisory fees is TWD 0.62 million.공시 • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025공시 • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025공시 • May 13Medix Inc., Annual General Meeting, Jun 27, 2025Medix Inc., Annual General Meeting, Jun 27, 2025.공시 • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025공시 • Mar 19Medix Inc. has completed an IPO in the amount of ¥1.84 billion.Medix Inc. has completed an IPO in the amount of ¥1.84 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,800,000 Price\Range: ¥800 Discount Per Security: ¥64 Security Name: Common Stock Security Type: Common Stock Securities Offered: 500,000 Price\Range: ¥800 Discount Per Security: ¥64매출 및 비용 세부 내역Medix가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TSE:331A 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비31 Mar 264,2564363,042031 Dec 254,1635172,905030 Sep 254,1545312,893030 Jun 254,1506392,902031 Mar 254,1618032,878031 Mar 244,1794892,936031 Mar 234,2734012,9070양질의 수익: 331A는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 331A의 현재 순 이익률 (10.2%)은 지난해 (19.3%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 331A의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: 331A은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: 331A은 지난 1년 동안 수익이 감소(-45.7%)하여 Media 업계 평균(30%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: 331A의 자본 수익률(12.2%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMedia 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/18 15:52종가2026/06/18 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Medix Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.
공시 • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026
공시 • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025
공시 • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025
공시 • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025
공시 • Jun 16Medix Inc. (TSE:331A) announces an Equity Buyback for 400,000 shares, representing 5.22% for ¥188 million.Medix Inc. (TSE:331A) announces a share repurchase program. Under the program, the company will repurchase up to 400,000 shares, representing 5.22% of its issued share capital (excluding treasury stock), for a total purchase price of ¥188 million. The shares will be repurchased at a price of ¥470 per share. The purpose of the program is to enable flexible capital policies that respond to changes in the business environment. As of March 31, 2026, the company had 7,667,500 issued shares (excluding treasury stock) and 412,500 treasury shares.
Reported Earnings • May 19Full year 2026 earnings released: EPS: JP¥56.04 (vs JP¥106 in FY 2025)Full year 2026 results: EPS: JP¥56.04 (down from JP¥106 in FY 2025). Revenue: JP¥4.26b (up 2.3% from FY 2025). Net income: JP¥436.0m (down 46% from FY 2025). Profit margin: 10% (down from 19% in FY 2025). The decrease in margin was driven by higher expenses.
공시 • May 14Medix Inc., Annual General Meeting, Jun 26, 2026Medix Inc., Annual General Meeting, Jun 26, 2026.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 12 June 2026. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.0%).
분석 기사 • Feb 16Why Investors Shouldn't Be Surprised By Medix Inc.'s (TSE:331A) Low P/EWith a price-to-earnings (or "P/E") ratio of 7.6x Medix Inc. ( TSE:331A ) may be sending bullish signals at the moment...
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥19.50 (vs JP¥27.25 in 3Q 2025)Third quarter 2026 results: EPS: JP¥19.50 (down from JP¥27.25 in 3Q 2025). Revenue: JP¥1.06b (down 8.8% from 3Q 2025). Net income: JP¥147.0m (down 29% from 3Q 2025). Profit margin: 14% (down from 18% in 3Q 2025). The decrease in margin was driven by lower revenue.
공시 • Nov 29Medix Inc. to Report Q3, 2026 Results on Feb 10, 2026Medix Inc. announced that they will report Q3, 2026 results on Feb 10, 2026
공시 • Sep 16Medix Inc. (TSE:331A) announces an Equity Buyback for 600,000 shares, representing 7.47% for ¥308.4 million.Medix Inc. (TSE:331A) announces a share repurchase program. Under the program, the company will repurchase up to 600,000 shares, representing 7.47% of its issued share capital (excluding treasury stock), for a total purchase price of ¥308.4 million. The shares will be repurchased at a price of ¥514 per share. The purpose of the program is to enable flexible capital policies that respond to changes in the business environment. As of September 16, 2025, the company had 8,030,000 issued shares (excluding treasury stock) and 50,000 treasury shares.
공시 • Sep 05Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million.Medix Inc. (TSE:331A) agreed to acquire 76.91% stake in Star To Asia Co., Ltd from Findstar Co., Ltd., Teppei Fujiwara and Masao Liang for TWD 185 million on September 4, 2025. A cash consideration of TWD 144 million will be paid by Medix Inc. Medix Inc. will pay an earnout payment of TWD 41 million cash. As part of consideration, TWD 185 million is paid towards common equity of Star To Asia Co., Ltd. The transaction is subject to consummation of due diligence investigation. The expected completion of the transaction is September 30, 2025. The advisory fees is TWD 0.62 million.
공시 • Sep 04Medix Inc. to Report Q2, 2026 Results on Nov 11, 2025Medix Inc. announced that they will report Q2, 2026 results on Nov 11, 2025
공시 • May 31Medix Inc. to Report Q1, 2026 Results on Aug 12, 2025Medix Inc. announced that they will report Q1, 2026 results on Aug 12, 2025
공시 • May 13Medix Inc., Annual General Meeting, Jun 27, 2025Medix Inc., Annual General Meeting, Jun 27, 2025.
공시 • Mar 22Medix Inc. to Report Fiscal Year 2025 Results on May 13, 2025Medix Inc. announced that they will report fiscal year 2025 results on May 13, 2025
공시 • Mar 19Medix Inc. has completed an IPO in the amount of ¥1.84 billion.Medix Inc. has completed an IPO in the amount of ¥1.84 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,800,000 Price\Range: ¥800 Discount Per Security: ¥64 Security Name: Common Stock Security Type: Common Stock Securities Offered: 500,000 Price\Range: ¥800 Discount Per Security: ¥64